NASDAQ:BCAX | News | Bicara Therapeutics Inc.

BCAX News

Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.

DateTypePublisherHeadlineSummary
2026-08-25Current reportSEC filingBicara Therapeutics Inc. filed Form 8-KBicara Therapeutics Inc. filed Form 8-K covering items 1.01,9.01.
2026-08-11Current reportSEC filingBicara Therapeutics Inc. filed Form 8-KBicara Therapeutics Inc. filed Form 8-K covering items 2.02,9.01.
2026-07-28Current reportSEC filingBicara Therapeutics Inc. filed Form 8-KBicara Therapeutics Inc. filed Form 8-K covering items 5.02,7.01,9.01.
2026-06-10Current reportSEC filingBicara Therapeutics Inc. filed Form 8-KBicara Therapeutics Inc. filed Form 8-K covering items 5.07.
2026-05-21Current reportSEC filingBicara Therapeutics Inc. filed Form 8-KBicara Therapeutics Inc. filed Form 8-K covering items 8.01,9.01.
2026-05-11Current reportSEC filingBicara Therapeutics Inc. filed Form 8-KBicara Therapeutics Inc. filed Form 8-K covering items 2.02,9.01.
2026-03-30Current reportSEC filingBicara Therapeutics Inc. filed Form 8-KBicara Therapeutics Inc. filed Form 8-K covering items 2.02,9.01.
2026-02-26Current reportSEC filingBicara Therapeutics Inc. filed Form 8-KBicara Therapeutics Inc. filed Form 8-K covering items 1.01,2.02,9.01.
2026-02-19Current reportSEC filingBicara Therapeutics Inc. filed Form 8-KBicara Therapeutics Inc. filed Form 8-K covering items 8.01,9.01.
2026-01-12Current reportSEC filingBicara Therapeutics Inc. filed Form 8-KBicara Therapeutics Inc. filed Form 8-K covering items 8.01,9.01.
2025-12-08Current reportSEC filingBicara Therapeutics Inc. filed Form 8-KBicara Therapeutics Inc. filed Form 8-K covering items 7.01,8.01,9.01.
2025-11-10Current reportSEC filingBicara Therapeutics Inc. filed Form 8-KBicara Therapeutics Inc. filed Form 8-K covering items 2.02,9.01.
2025-08-12Current reportSEC filingBicara Therapeutics Inc. filed Form 8-KBicara Therapeutics Inc. filed Form 8-K covering items 2.02,9.01.
2025-06-12Current reportSEC filingBicara Therapeutics Inc. filed Form 8-KBicara Therapeutics Inc. filed Form 8-K covering items 5.07.
2025-06-06Current reportSEC filingBicara Therapeutics Inc. filed Form 8-KBicara Therapeutics Inc. filed Form 8-K covering items 1.01,9.01.
2025-05-13Current reportSEC filingBicara Therapeutics Inc. filed Form 8-KBicara Therapeutics Inc. filed Form 8-K covering items 2.02,9.01.
2025-03-27Current reportSEC filingBicara Therapeutics Inc. filed Form 8-KBicara Therapeutics Inc. filed Form 8-K covering items 2.02,9.01.
2025-01-13Current reportSEC filingBicara Therapeutics Inc. filed Form 8-KBicara Therapeutics Inc. filed Form 8-K covering items 7.01,9.01.
2024-11-12Current reportSEC filingBicara Therapeutics Inc. filed Form 8-KBicara Therapeutics Inc. filed Form 8-K covering items 2.02,7.01,9.01.
2024-09-16Current reportSEC filingBicara Therapeutics Inc. filed Form 8-KBicara Therapeutics Inc. filed Form 8-K covering items 5.03,9.01.